Mary Kay Fenton's Net Worth
$1.91 Million
Who is Mary Kay Fenton?
Mary Kay Fenton has an estimated net worth of $1.91 Million. This is based on reported shares across multiple companies, which include Talaris Therapeutics, Inc., Oncorus, Inc., ACHILLION PHARMACEUTICALS INC, and Cullinan Therapeutics, Inc..
SEC CIK
Mary Kay Fenton's CIK is 0001378589
Past Insider Trading and Trends
2022 was Mary Kay Fenton's most active year for acquiring shares with 3 total transactions. Mary Kay Fenton's most active month to acquire stocks was the month of November. 2011 was Mary Kay Fenton's most active year for disposing of shares, totalling 4 transactions. Mary Kay Fenton's most active month to dispose stocks was the month of December. 2015 saw Mary Kay Fenton paying a total of $98,175.00 for 56,625 shares, this is the most they've acquired in one year. In 2015 Mary Kay Fenton cashed out on 113,250 shares for a total of $648,480.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Talaris Therapeutics, Inc. (TRML) Snapshot price: $16.11
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.98% | -12.95K |
$3.08 | -$39,873.68 | 68.05K |
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +8,000.00% | 80K |
—
|
—
| 81K |
Sep 10
| |||
Form 4
|
∞
| 1K |
$13.00 | $13,000.00 | 1K |
Dec 31 - Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncorus, Inc. (ONCR) Snapshot price: $0.024
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACHILLION PHARMACEUTICALS INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
∞
| 2.5K |
$4.11 | $10,275.00 | 2.5K |
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
$5.57 | -$392,805.00 |
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
$10.00 | -$157,500.00 |
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
| -100.00% | -4.38K |
$6.41 | -$151,362.50 |
0
|
Jan 9 - Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| -49.28% | -4.25K |
$7.50 | -$31,875.00 | 4.38K |
Apr 5 - Apr 6
| |||
Form 4
| -31.68% | -4.00K |
$7.50 | -$30,000.00 | 8.63K |
Mar 30
| |||
Form 4
| -40.94% | -8.75K |
$5.00 | -$43,750.00 | 12.63K |
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +17.12% | 3.13K |
$1.60 | $5,000.00 | 21.38K |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
∞
| 1.25K |
$1.60 | $2,000.00 | 1.25K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cullinan Therapeutics, Inc. (CGEM) Snapshot price: $17.98
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||